This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: 2Seventy Bio, Inc., Novo Nordisk A/s. Active years: 2022-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022-2026
Title: Innovations by Baeckseung Lee in Genome Editing
Introduction
Baeckseung Lee is an accomplished inventor based in Kenmore, WA (US). He has made significant contributions to the field of genome editing, particularly in the development of methods and compositions that enhance multiplex genome editing.
Latest Patents
Baeckseung Lee holds a patent for "Donor repair templates multiplex genome editing." This patent provides improved compositions and methods for multiplex genome editing. The disclosure further includes genome-edited cells aimed at preventing, treating, or ameliorating symptoms associated with various conditions, including hemoglobinopathies, cancers, infectious diseases, autoimmune diseases, inflammatory diseases, and immunodeficiencies.
Career Highlights
Baeckseung Lee is currently employed at 2seventy Bio, Inc., where he continues to innovate in the field of biotechnology. His work focuses on advancing genome editing technologies that have the potential to revolutionize treatments for a range of diseases.
Collaborations
Baeckseung Lee collaborates with Alexander Astrakhan, contributing to the advancement of their shared goals in the field of genome editing.
Conclusion
Baeckseung Lee's innovative work in multiplex genome editing showcases his commitment to improving healthcare through advanced biotechnology. His contributions are paving the way for new treatments and therapies that could significantly impact patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile